anti-interleukin 6 monoclonal antibody ALD518

A humanized monoclonal antibody directed against the pro-inflammatory cytokine interleukin-6 (Il-6) with potential immunomodulating activity. Upon administration, anti-interleukin 6 monoclonal antibody ALD518 binds to and blocks the activity of IL-6, which may mitigate the catabolic effects of IL-6. Check for active clinical trials using this agent. (NCI Thesaurus)

Related Posts